Skip to main content
. 2023 Apr 2;11(4):1071. doi: 10.3390/biomedicines11041071

Figure 1.

Figure 1

Immune checkpoints and corresponding inhibitors. At tumor sites, PD-1/PD-L1 interaction leads to T cells’ death or inhibition. Treg cells may express CTLA-4 at the lymph nodes, which provides negative feedback signals. APC: antigen-presenting cell; TCR: T cell receptor; MHC: major histocompatibility complex; PD-1: programmed death-1; PD-L1: programmed death ligand-1; CTLA-4: cytotoxic T lymphocyte antigen-4.